Literature DB >> 32489750

Recurrence of Pheochromocytoma With Metastases After Resection of Primary Tumor.

Sharini Venugopal1, Mamta Chhabria1, Michael Quartuccio2,3.   

Abstract

Pheochromocytomas and paragangliomas are rare tumors that arise from the chromaffin cells of the adrenal medulla or sympathetic paravertebral ganglia, respectively. Long-term surveillance is recommended regardless of the thoroughness of surgical resection. Here, we present a patient who was diagnosed with pheochromocytoma who underwent right adrenalectomy and was lost to follow up. She presented 15 years later with recurrence and was found to have multiple metastases. Subsequent genetic testing was also negative.
Copyright © 2020, Venugopal et al.

Entities:  

Keywords:  benign; malignant; mutation; pheochromocytoma; recurrence; size

Year:  2020        PMID: 32489750      PMCID: PMC7255549          DOI: 10.7759/cureus.8328

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  7 in total

1.  Prognostic markers in pheochromocytoma.

Authors:  M R Clarke; R J Weyant; C G Watson; S E Carty
Journal:  Hum Pathol       Date:  1998-05       Impact factor: 3.466

2.  Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979.

Authors:  C M Beard; S G Sheps; L T Kurland; J A Carney; J T Lie
Journal:  Mayo Clin Proc       Date:  1983-12       Impact factor: 7.616

3.  Predictors of recurrence in pheochromocytoma.

Authors:  Danielle Press; Muhammet Akyuz; Cem Dural; Shamil Aliyev; Rosebel Monteiro; Jeff Mino; Jamie Mitchell; Amir Hamrahian; Allan Siperstein; Eren Berber
Journal:  Surgery       Date:  2014-11-11       Impact factor: 3.982

Review 4.  New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.

Authors:  Joakim Crona; David Taïeb; Karel Pacak
Journal:  Endocr Rev       Date:  2017-12-01       Impact factor: 19.871

5.  Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years.

Authors:  Oksana Hamidi; William F Young; Nicole M Iñiguez-Ariza; Nana Esi Kittah; Lucinda Gruber; Cristian Bancos; Shrikant Tamhane; Irina Bancos
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

6.  Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma.

Authors:  Laurence Amar; Aude Servais; Anne-Paule Gimenez-Roqueplo; Franck Zinzindohoue; Gilles Chatellier; Pierre-François Plouin
Journal:  J Clin Endocrinol Metab       Date:  2005-01-11       Impact factor: 5.958

7.  Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.

Authors:  Jacques W M Lenders; Quan-Yang Duh; Graeme Eisenhofer; Anne-Paule Gimenez-Roqueplo; Stefan K G Grebe; Mohammad Hassan Murad; Mitsuhide Naruse; Karel Pacak; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2014-06       Impact factor: 5.958

  7 in total
  1 in total

1.  Postoperative Recurrences in Patients Operated for Pheochromocytomas and Paragangliomas: New Data Supporting Lifelong Surveillance.

Authors:  Stefanie Parisien-La Salle; Jessica Chbat; André Lacroix; Paul Perrotte; Pierre Karakiewicz; Issam Saliba; Xuan Kim Le; Harold J Olney; Isabelle Bourdeau
Journal:  Cancers (Basel)       Date:  2022-06-14       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.